Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture

SummaryCultures of fetal rat brain cell aggregates and tumor spheroids from the human glioma cell line GaMG were treated with epidermal growth factor (EGF), fibroblast growth factor (FGF) or isoforms of platelet-derived growth factor (PDGF AA or BB). Radioreceptor binding studies displayed a high binding capacity for EGF and FGF, but not binding of PDGF isoforms in the glioma cells. In serum-free culture, 10 ng/ml of both EGF and FGF caused increased growth and cell shedding in the tumor spheroids, whereas PDGF produced no such effect. Similarly, EGF and FGF stimulated tumor cell migration. EGF increased the proliferation and outgrowth of glial fibrillary acidic protein (GFAP)-positive cells in brain cell aggregates, while PDGF AA and BB both stimulated the outgrowth of oligodendrocyte-like cells which were negative for GFAP and neuron-specific enolase. FGF stimulated GFAP+ as well as GFAP− cell types. In co-culture experiments using brain aggregates and tumor spheroids, both EGF and FGF treatment caused increased tumor cell invasion. PDGF had no effect on the tumor cells, but instead stimulated the proliferation of oligodendrocyte-like cells in the brain aggregates. The present results indicate that growth factors may facilitate glioma growth as well as invasiveness, and cause reactive changes in the surrounding normal tissue.

[1]  L. Akslen,et al.  Characteristics of human and rat glioma cells grown in a defined medium. , 1988, Anticancer research.

[2]  R. Bjerkvig,et al.  Effect of alkyl-lysophospholipid on glioblastoma cell invasion into fetal rat brain tissue in vitro. , 1991, Cancer research.

[3]  M. Laiho,et al.  Growth factors in the regulation of pericellular proteolysis: a review. , 1989, Cancer research.

[4]  J. McKerrow,et al.  Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. , 1990, Cancer research.

[5]  G. Sherbet,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTORS AND OESTROGEN RECEPTORS IN HUMAN BREAST CANCER , 1985, The Lancet.

[6]  M. Bennett,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HUMAN BLADDER CANCER: COMPARISON OF INVASIVE AND SUPERFICIAL TUMOURS , 1985, The Lancet.

[7]  I. Pastan,et al.  Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. , 1987, Science.

[8]  R. Bjerkvig,et al.  Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo. , 1986, Cancer research.

[9]  I. Grimstad.  Direct evidence that cancer cell locomotion contributes importantly to invasion. , 1987, Experimental cell research.

[10]  Hermona Soreq,et al.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin , 1985, Nature.

[11]  M. Waterfield,et al.  Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. , 1988, Nature.

[12]  M. Schwab,et al.  Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease , 1988, The Journal of cell biology.

[13]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[14]  C. Cotman,et al.  The control of glial populations in brain: Changes in astrocyte mitogenic and morphogenic factors in response to injury , 1985, Brain Research.

[15]  R. Bjerkvig,et al.  Multicellular tumor spheroids from human gliomas maintained in organ culture. , 1990, Journal of neurosurgery.

[16]  W. Richardson,et al.  Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture , 1988, Nature.

[17]  C. Heldin,et al.  Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells , 1982, Journal of neuroscience research.

[18]  R. Bjerkvig,et al.  Multicellular tumor spheroids in serum-free culture. , 1989, Anticancer research.

[19]  M. Westphal,et al.  Growth Factor Biology and Oncogene Activation in Human Gliomas and Their Implications for Specific Therapeutic Concepts , 1989, Neurosurgery.

[20]  D. Rifkin,et al.  Correlation of cell migration, cell invasion, receptor number, proteinase production, and basic fibroblast growth factor levels in endothelial cells , 1990, The Journal of cell biology.

[21]  N. Hagag,et al.  Role of epidermal growth factor in the expression of A431 cancer cell protease and red blood cell cytotoxicity. , 1989, Cancer research.

[22]  J. Barrett,et al.  Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas. , 1989, The American journal of pathology.

[23]  D. Bigner,et al.  Anti-GM2 monoclonal antibodies induce necrosis in GM2-rich cultures of a human glioma cell line. , 1991, Cancer research.

[24]  I. Weinstein,et al.  Epidermal growth factor, like phorbol esters, induces plasminogen activator in HeLa cells , 1978, Nature.

[25]  P. Humphrey,et al.  Growth effects of epidermal growth factor (EGF) and a monoclonal antibody against the EGF receptor on four glioma cell lines , 1988, Acta Neuropathologica.

[26]  I. Pollack,et al.  Response of malignant glioma cell lines to epidermal growth factor and platelet-derived growth factor in a serum-free medium. , 1990, Journal of neurosurgery.

[27]  C. Heldin,et al.  Clonal variation in the production of a platelet-derived growth factor-like protein and expression of corresponding receptors in a human malignant glioma. , 1986, Cancer research.

[28]  E. Hoal,et al.  Molecular species of plasminogen activators secreted by normal and neoplastic human cells. , 1980, Cancer research.

[29]  D. Orth,et al.  Human brain tumor-associated urinary high molecular weight transforming growth factor: a high molecular weight form of epidermal growth factor. , 1987, Cancer research.

[30]  M. Lund-Johansen.  Interactions between human glioma cells and fetal rat brain aggregates studied in a chemically defined medium. , 1990, Invasion & metastasis.

[31]  G. Sherbet,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTORS AND ESTROGEN-RECEPTORS IN HUMAN-BREAST CANCER , 1985 .

[32]  C. Heldin,et al.  A PLATELET‐DERIVED GROWTH FACTOR ANALOG PRODUCED BY A HUMAN CLONAL GLIOMA CELL LINE * , 1982, Annals of the New York Academy of Sciences.

[33]  D. W. Weiss,et al.  Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumor resistance and enhancement in strain A mice infected with mammary tumor virus. , 1966, Cancer research.

[34]  O D Laerum,et al.  Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. , 1990, Cancer research.

[35]  C. Heldin,et al.  Growth factors and oncogenes in human malignant glioma. , 1985, Neurologic clinics.

[36]  R. Bjerkvig,et al.  Interaction between human brain tumour biopsies and fetal rat brain tissue in vitro , 1990, Acta Neuropathologica.

[37]  D. Rifkin,et al.  Induction of Proteases and Protease Inhibitors by Growth Factors , 1990 .

[38]  R. Alterman,et al.  Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line. , 1990, Cancer research.

[39]  K. McCarthy,et al.  Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue , 1980, The Journal of cell biology.

[40]  M. Sporn,et al.  Autocrine secretion and malignant transformation of cells. , 1980, The New England journal of medicine.

[41]  T. Libermann,et al.  Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. , 1988, Cancer research.

[42]  J. Adams,et al.  Pathology of Tumours of the Nervous System , 1978 .